Literature DB >> 27236327

Malignant gliomas induce and exploit astrocytic mesenchymal-like transition by activating canonical Wnt/β-catenin signaling.

Ping Lu1, Yajing Wang1, Xiuting Liu1, Hong Wang1, Xin Zhang1, Kequan Wang1, Qing Wang2, Rong Hu3.   

Abstract

The complex microenvironment of malignant gliomas plays a dynamic and usually cancer-promoting role in glioma progression. Astrocytes, the major stromal cells in the brain, can be activated by glioma microenvironment, resulting in a layer of reactive astrocytes surrounding the gliomas. Reactive astrocytes are universally characterized with the upregulation of glial fibrillary protein and glycoprotein podoplanin. In this work, we investigated the role of reactive astrocytes on malignant glioma microenvironment and the potential mechanism by which glioma cells activated the tumor-associated astrocytes (TAAs). The reactive astrocytes were observed around gliomas in the intracranial syngeneic implantation of rat C6 and mouse GL261 glioma cells in vivo, as well as primary astrocytes cultured with glioma cells condition medium in vitro. Besides, reactive astrocytes exhibited distinct epithelial-to-mesenchymal (-like) transition and enhanced migration and invasion activity, with the decrease of E-cadherin and concomitant increase of vimentin and matrix metalloproteinases. Furthermore, canonical Wnt/β-catenin signaling was activated in TAAs. The Wnt/β-catenin pathway inhibitor XAV939 and β-catenin plasmid were used to verify the regulation of Wnt/β-catenin signaling on TAAs and their invasion ability. Taken together, our findings established that glioma cells remarkably activated astrocytes via upregulating Wnt/β-catenin signaling, with obviously mesenchymal-like transition and increased migration and invasion ability, indicating that glioma cells may stimulate adjacent astrocytes to degrade extracellular matrix and thereby promoting tumor invasiveness.

Entities:  

Keywords:  GFAP; Malignant glioma; PDPN; Tumor microenvironment; Tumor-associated astrocytes (TAAs); Wnt/β-catenin signaling

Mesh:

Year:  2016        PMID: 27236327     DOI: 10.1007/s12032-016-0778-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  33 in total

1.  Beta-catenin expression in human neural cell lines following exposure to cytokines and growth factors.

Authors:  J Satoh; Y Kuroda
Journal:  Neuropathology       Date:  2000-06       Impact factor: 1.906

Review 2.  Wnt/beta-catenin signaling in glioma.

Authors:  Kailiang Zhang; Junxia Zhang; Lei Han; Peiyu Pu; Chunsheng Kang
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

Review 3.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

4.  Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.

Authors:  Kazuhiko Mishima; Yukinari Kato; Mika Kato Kaneko; Ryo Nishikawa; Takanori Hirose; Masao Matsutani
Journal:  Acta Neuropathol       Date:  2006-04-05       Impact factor: 17.088

5.  Astrocytes promote glioma invasion via the gap junction protein connexin43.

Authors:  W C Sin; Q Aftab; J F Bechberger; J H Leung; H Chen; C C Naus
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

6.  Signaling pathways in the activation of mast cells cocultured with astrocytes and colocalization of both cells in experimental allergic encephalomyelitis.

Authors:  Dae Yong Kim; Dooil Jeoung; Jai Youl Ro
Journal:  J Immunol       Date:  2010-05-28       Impact factor: 5.422

Review 7.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

Review 8.  The role of astrocytes in the progression of brain cancer: complicating the picture of the tumor microenvironment.

Authors:  Amanda L Placone; Alfredo Quiñones-Hinojosa; Peter C Searson
Journal:  Tumour Biol       Date:  2015-10-22

9.  Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas.

Authors:  Koji Shindo; Shinichi Aishima; Kenoki Ohuchida; Kenji Fujiwara; Minoru Fujino; Yusuke Mizuuchi; Masami Hattori; Kazuhiro Mizumoto; Masao Tanaka; Yoshinao Oda
Journal:  Mol Cancer       Date:  2013-12-20       Impact factor: 27.401

10.  Astrocytes directly influence tumor cell invasion and metastasis in vivo.

Authors:  Ling Wang; Stephanie M Cossette; Kevin R Rarick; Jill Gershan; Michael B Dwinell; David R Harder; Ramani Ramchandran
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

View more
  10 in total

Review 1.  The Unwanted Cell Migration in the Brain: Glioma Metastasis.

Authors:  Xue Tao Qi; Jiang Shan Zhan; Li Ming Xiao; Lina Li; Han Xiao Xu; Zi Bing Fu; Yan Hao Zhang; Jing Zhang; Xi Hua Jia; Guo Ge; Rui Chao Chai; Kai Gao; Albert Cheung Hoi Yu
Journal:  Neurochem Res       Date:  2017-05-06       Impact factor: 3.996

Review 2.  Contribution of the Wnt Pathway to Defining Biology of Glioblastoma.

Authors:  Marton Tompa; Ferenc Kalovits; Adam Nagy; Bernadette Kalman
Journal:  Neuromolecular Med       Date:  2018-09-26       Impact factor: 3.843

Review 3.  Glioma Cell and Astrocyte Co-cultures As a Model to Study Tumor-Tissue Interactions: A Review of Methods.

Authors:  Ivan V Chekhonin; Dimitry A Chistiakov; Nadezhda F Grinenko; Olga I Gurina
Journal:  Cell Mol Neurobiol       Date:  2018-05-10       Impact factor: 5.046

Review 4.  Remodeling the blood-brain barrier microenvironment by natural products for brain tumor therapy.

Authors:  Xiao Zhao; Rujing Chen; Mei Liu; Jianfang Feng; Jun Chen; Kaili Hu
Journal:  Acta Pharm Sin B       Date:  2017-09-01       Impact factor: 11.413

5.  Tunicamycin inhibits progression of glioma cells through downregulation of the MEG-3-regulated wnt/β-catenin signaling pathway.

Authors:  Xin Li; Lei Xue; Qin Peng
Journal:  Oncol Lett       Date:  2018-04-03       Impact factor: 2.967

6.  MEG-3-mediated Wnt/β-catenin signaling pathway controls the inhibition of tunicamycin-mediated viability in glioblastoma.

Authors:  Xiangyu Cui; Dezhou Sun; Bin Shen; Xin Wang
Journal:  Oncol Lett       Date:  2018-06-28       Impact factor: 2.967

Review 7.  Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors.

Authors:  Diana Matias; Joana Balça-Silva; Grazielle C da Graça; Caroline M Wanjiru; Lucy W Macharia; Carla Pires Nascimento; Natalia R Roque; Juliana M Coelho-Aguiar; Cláudia M Pereira; Marcos F Dos Santos; Luciana S Pessoa; Flavia R S Lima; Alberto Schanaider; Valéria P Ferrer; Vivaldo Moura-Neto
Journal:  Front Cell Neurosci       Date:  2018-08-03       Impact factor: 5.505

Review 8.  WNT signaling at the intersection between neurogenesis and brain tumorigenesis.

Authors:  Maisa I Alkailani; Mohamed Aittaleb; Fadel Tissir
Journal:  Front Mol Neurosci       Date:  2022-10-04       Impact factor: 6.261

9.  Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.

Authors:  Kelly L Hamilton; Stephanie A Sheehan; Edward P Retzbach; Clinton A Timmerman; Garret B Gianneschi; Patrick J Tempera; Premalatha Balachandran; Gary S Goldberg
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-17       Impact factor: 4.553

10.  Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches.

Authors:  H P Ellis; C E McInerney; D Schrimpf; F Sahm; A Stupnikov; M Wadsley; C Wragg; P White; K M Prise; D G McArt; K M Kurian
Journal:  J Oncol       Date:  2019-12-31       Impact factor: 4.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.